Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
10.24
-0.45 (-4.21%)
At close: Dec 5, 2025, 4:00 PM EST
10.44
+0.20 (1.95%)
After-hours: Dec 5, 2025, 6:53 PM EST
CRBP Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for CRBP stock have an average target of 50.29, with a low estimate of 38 and a high estimate of 75. The average target predicts an increase of 391.11% from the current stock price of 10.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CRBP stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 4 | 4 | 4 |
| Buy | 6 | 6 | 6 | 5 | 5 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 11 | 9 | 9 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $55 → $53 | Buy | Maintains | $55 → $53 | +417.58% | Nov 13, 2025 |
| Wedbush | Wedbush | Buy Maintains $31 → $38 | Buy | Maintains | $31 → $38 | +271.09% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +290.62% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +290.62% | Sep 17, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $56 → $53 | Buy | Maintains | $56 → $53 | +417.58% | Aug 6, 2025 |
Financial Forecast
Revenue This Year
2.04M
Revenue Next Year
4.08M
from 2.04M
Increased by 100.00%
EPS This Year
-6.94
from -3.68
EPS Next Year
-5.54
from -6.94
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 10.5M | 21.0M | ||||
| Avg | 2.0M | 4.1M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 929.4% | ||||
| Avg | - | 100.0% | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.89 | -4.10 | ||||
| Avg | -6.94 | -5.54 | ||||
| Low | -12.31 | -7.13 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.